Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-02-17

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$2.0bn reported value +13.9% vs Q3 2025
27positions
73.7%in top 10
1 new 7 added 4 reduced 7 sold out vs Q3 2025

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $641.1m31.67% 31.67% UnchangedShares held: Q1 2025 8.5m, Q2 2025 8.5m, Q3 2025 8.5m, Q4 2025 8.5m
2 ORUKA THERAPEUTICS INC COM ORKA ORKA 4,148,428 $125.7m6.21% 6.21% UnchangedShares held: Q1 2025 4.1m, Q2 2025 4.1m, Q3 2025 4.1m, Q4 2025 4.1m
3 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $120.8m5.97% 5.97% UnchangedShares held: Q1 2025 3.9m, Q2 2025 3.9m, Q3 2025 3.9m, Q4 2025 3.9m
4 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 3,685,448 $120.7m5.96% 5.96% AddedShares held: Q1 2025 2.7m, Q2 2025 2.7m, Q3 2025 2.7m, Q4 2025 3.7m +1.0m +1,000,000 37.2%
5 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,728,985 $108.7m5.37% 5.37% UnchangedShares held: Q1 2025 6.7m, Q2 2025 6.7m, Q3 2025 6.7m, Q4 2025 6.7m
6 OCULAR THERAPEUTIX INC COM OCUL OCUL 7,315,547 $88.8m4.39% 4.39% ReducedShares held: Q1 2025 12.8m, Q2 2025 12.8m, Q3 2025 13.2m, Q4 2025 7.3m -5.8m -5,845,915 -44.4%
7 SAVARA INC COM SVRA SVRA 13,740,375 $82.9m4.09% 4.09% AddedShares held: Q1 2025 3.3m, Q2 2025 8.9m, Q3 2025 12.7m, Q4 2025 13.7m +1.1m +1,059,332 8.3%
8 COGENT BIOSCIENCES INC COM COGT COGT 2,000,000 $71.0m3.51% 3.51% ReducedShares held: Q1 2025 5.7m, Q2 2025 4.8m, Q3 2025 4.0m, Q4 2025 2.0m -2.0m -2,000,000 -50.0%
9 ERASCA INC COM ERAS ERAS 17,857,083 $66.4m3.28% 3.28% UnchangedShares held: Q1 2025 16.2m, Q2 2025 17.9m, Q3 2025 17.9m, Q4 2025 17.9m
10 CYTOMX THERAPEUTICS INC COM CTMX CTMX 15,561,500 $66.3m3.27% 3.27% UnchangedShares held: Q1 2025 0, Q2 2025 14.0m, Q3 2025 15.6m, Q4 2025 15.6m
11 MAZE THERAPEUTICS INC COM MAZE MAZE 1,548,569 $64.2m3.17% 3.17% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 1.2m, Q4 2025 1.5m +317.8k +317,800 25.8%
12 JADE BIOSCIENCES INC COM NEW JBIO JBIO 3,220,364 $49.7m2.45% 2.45% UnchangedShares held: Q1 2025 0, Q2 2025 3.2m, Q3 2025 3.2m, Q4 2025 3.2m
13 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 3,226,331 $49.7m2.45% 2.45% UnchangedShares held: Q1 2025 4.0m, Q2 2025 4.0m, Q3 2025 3.2m, Q4 2025 3.2m
14 ORIC PHARMACEUTICALS INC COM ORIC ORIC 5,676,230 $46.4m2.29% 2.29% ReducedShares held: Q1 2025 3.2m, Q2 2025 6.6m, Q3 2025 6.6m, Q4 2025 5.7m -920.7k -920,655 -14.0%
15 ENGENE HOLDINGS INC COM COM 4,771,414 $43.1m2.13% 2.13% ReducedShares held: Q1 2025 5.0m, Q2 2025 5.0m, Q3 2025 5.0m, Q4 2025 4.8m -275.0k -275,000 -5.5%
16 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $42.5m2.10% 2.10% UnchangedShares held: Q1 2025 2.2m, Q2 2025 2.2m, Q3 2025 2.2m, Q4 2025 2.2m
17 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,000,000 $41.2m2.04% 2.04% AddedShares held: Q1 2025 1.7m, Q2 2025 1.0m, Q3 2025 960.8k, Q4 2025 1.0m +39.2k +39,197 4.1%
18 UPSTREAM BIO INC COM UPB UPB 1,169,298 $31.7m1.57% 1.57% UnchangedShares held: Q1 2025 2.3m, Q2 2025 2.3m, Q3 2025 1.2m, Q4 2025 1.2m
19 CYBIN INC COM NEW COM NEW 3,840,250 $31.4m1.55% 1.55% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 3.8m
20 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 5,345,115 $28.0m1.38% 1.38% AddedShares held: Q1 2025 5.0m, Q2 2025 4.6m, Q3 2025 4.6m, Q4 2025 5.3m +713.9k +713,899 15.4%
21 VOR BIOPHARMA INC COM NEW VOR VOR 1,943,766 $25.4m1.26% 1.26% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 500.0k, Q4 2025 1.9m +1.4m +1,443,800 288.8%
22 CRESCENT BIOPHARMA INC. COM CBIO CBIO 2,133,576 $25.3m1.25% 1.25% AddedShares held: Q1 2025 0, Q2 2025 1.4m, Q3 2025 1.4m, Q4 2025 2.1m +745.7k +745,712 53.7%
23 SEPTERNA INC COM SEPN SEPN 610,808 $17.0m0.84% 0.84% UnchangedShares held: Q1 2025 0, Q2 2025 540.5k, Q3 2025 610.8k, Q4 2025 610.8k
24 SURROZEN INC COM NEW SRZN SRZN 632,931 $14.3m0.71% 0.71% UnchangedShares held: Q1 2025 632.9k, Q2 2025 632.9k, Q3 2025 632.9k, Q4 2025 632.9k
25 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $14.3m0.71% 0.71% UnchangedShares held: Q1 2025 1.4m, Q2 2025 1.4m, Q3 2025 1.4m, Q4 2025 1.4m
26 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $6.9m0.34% 0.34% UnchangedShares held: Q1 2025 1.6m, Q2 2025 1.6m, Q3 2025 1.6m, Q4 2025 1.6m
27 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 987,259 $839.2k0.04% 0.04% UnchangedShares held: Q1 2025 987.3k, Q2 2025 987.3k, Q3 2025 987.3k, Q4 2025 987.3k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
METSERA INC 3,750,662 $196.3m3.8m shares
CIDARA THERAPEUTICS INC CDTX CDTX 946,788 $90.7m946.8k shares
ABIVAX SA ABVX ABVX 576,729 $49.0m576.7k shares
ASTRIA THERAPEUTICS INC CATB CATB 2,457,348 $17.9m2.5m shares
PHARVARIS N V PHVS PHVS 674,599 $16.8m674.6k shares
PERCEPTIVE CAP SOLUTIONS COR FRNM FRNM 750,000 $8.0m750.0k shares
TENAX THERAPEUTICS INC TENX TENX 437,708 $3.3m437.7k shares